DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Epigral Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·13 Oct 2026, 12:23 pm

Epigral

Epigral Limited has announced that it will be holding an institutional investor meet or conference call. This event is a scheduled update for the market, where the company management is expected to discuss its business performance and future outlook directly with analysts and investors.

For retail investors, this meeting is significant as it provides an opportunity to understand the company's strategic direction and operational health. It helps in gauging management sentiment and can offer clarity on upcoming projects or market conditions.

Investors should watch for any specific guidance or commentary regarding the company's growth trajectory and financial targets following the conclusion of the meeting.